Management of drug-related problems including drug-drug interactions caused by nirmatrelvir/ritonavir in paediatric patients with SARS-CoV-2

Nadir Yalcin*, GROUP investigators, Kutay Demirkan

*Corresponding author for this work

Research output: Contribution to journalEditorialAcademicpeer-review

Original languageEnglish
Article numberarchdischild-2022-324168
Number of pages2
JournalArchives of Disease in Childhood
Early online date30 Sep 2022
Publication statusE-pub ahead of print - 30 Sep 2022

Bibliographical note

© Author(s) (or their employer(s)) 2022.

Cite this